Categories
Blood Cancer

Last Week in LA and Prepping for Flight Attendant Training ✈️ [Video]

Last week in LA, for a short while. Soooo excited to start flight attendant training so soon!love, kamkeep up with my journey here 🤠✰ ig: kam schalk✰ twitter: kamschalk✰ vsco: kammck✰ soundcloud: kammckA little bit about me:1. I am 23 years old!!2. I SURVIVED Stage 4 Hodgkin’s Lymphoma3. I am a college grad. omg getting old.Music:Music by Joey White – Trapped in the Marsh With You (Woman in the Dunes) – https://thmatc.co/?l=310056B6Music by Karrit Music – Lofi Sax Type Beat – https://thmatc.co/?l=7437EAB8Music by Frythm – Illusions – https://thmatc.co/?l=0C0CBBC5Music by Mr. Jello – Slow Down – https://thmatc.co/?l=C03A1870#hodgkinslymphoma​​​​ #cancersurvivor​​​​ #kamstrong

Categories
Blood Cancer

IMS session highlights: clinical challenges in multiple myeloma [Video]

Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center, San Antonio, Texas, shares her highlights from the session on clinical challenges in multiple myeloma that was held at this year’s IMS meeting, commenting on the management of toxicities associated with immunotherapies, the importance of better diagnosing amyloidosis, and learning how to better use and sequence available immunotherapeutics. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Categories
Blood Cancer

Altered metabolism in multiple myeloma [Video]

Mala Shanmugam, MS, PhD , Emory School of Medicine, Atlanta, GA, comments on altered metabolism in multiple myeloma, highlighting the importance of better understanding the impact of metabolic alterations on therapy sensitivity and resistance. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Categories
Blood Cancer

Efficacy of trametinib in patients with multiple myeloma with NRAS and KRAS mutations [Video]

Meral Beksac, MD, Ankara University, Ankara, Turkey, talks on the efficacy of trametinib in patients with triple-class refractory multiple myeloma who are KRAS or NRAS-mutated. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.